首页|NF-κB in biology and targeted therapy:new insights and translational implications

NF-κB in biology and targeted therapy:new insights and translational implications

扫码查看
NF-κB signaling has been discovered for nearly 40 years.Initially,NF-KB signaling was identified as a pivotal pathway in mediating inflammatory responses.However,with extensive and in-depth investigations,researchers have discovered that its role can be expanded to a variety of signaling mechanisms,biological processes,human diseases,and treatment options.In this review,we first scrutinize the research process of NF-κB signaling,and summarize the composition,activation,and regulatory mechanism of NF-κB signaling.We investigate the interaction of NF-κB signaling with other important pathways,including PI3K/AKT,MAPK,JAK-STAT,TGF-p,Wnt,Notch,Hedgehog,and TLR signaling.The physiological and pathological states of NF-κB signaling,as well as its intricate involvement in inflammation,immune regulation,and tumor microenvironment,are also explicated.Additionally,we illustrate how NF-κB signaling is involved in a variety of human diseases,including cancers,inflammatory and autoimmune diseases,cardiovascular diseases,metabolic diseases,neurological diseases,and COVID-19.Further,we discuss the therapeutic approaches targeting NF-κB signaling,including IKK inhibitors,monoclonal antibodies,proteasome inhibitors,nuclear translocation inhibitors,DNA binding inhibitors,TKIs,non-coding RNAs,immunotherapy,and CAR-T.Finally,we provide an outlook for research in the field of NF-κB signaling.We hope to present a stereoscopic,comprehensive NF-κB signaling that will inform future research and clinical practice.

Qing Guo、Yizi Jin、Xinyu Chen、Xiaomin Ye、Xin Shen、Mingxi Lin、Cheng Zeng、Teng Zhou、Jian Zhang

展开 >

Department of Medical Oncology,Fudan University Shanghai Cancer Center,No.270,Dong'an Road,Shanghai 200032,China

Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China

State Key Laboratory of Oncogenes and Related Genes,Renji-Med-X Stem Cell Research Center,Shanghai Cancer Institute &Department of Urology,Ren Ji Hospital,School of Medicine and School of Biomedical Engineering,Shanghai Jiao Tong University,Shanghai 200127,PR China

Department of Cardiology,the First Affiliated Hospital of Sun Yat-Sen University,58 Zhongshan 2nd Road,Guangzhou 510080,China

Department of Neurology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China

展开 >

国家自然科学基金国家自然科学基金Project of Shanghai Municipal Health CommissionCSCO-ROCHE Cancer Research Fund(2019)Chinese Young Breast Experts Research ProjectBeijing Science and Technology Innovation Medical Development Foundation Key Project

8207291582373359202140397Y-2019Roche-171CYBER-2021-001KC2022-ZZ-0091-6

2024

信号转导与靶向治疗(英文)

信号转导与靶向治疗(英文)

CSTPCD
ISSN:
年,卷(期):2024.9(4)
  • 617